Based on the findings, we believe that the elevated serum levels of sPD-L1 in the CLL group are mostly related to the disease pathophysiology as a slowly increasing and resistant to apoptosis lymphoid cells able to escape immunosurveillance26. This evidence concerns the gene SPDL1 and B-cell chronic lymphocytic leukemia.